The complaint
SōRSE Technology Corporation v. Vertosa, Inc., No. 4:26-cv-14378, is a complaint for patent infringement filed in the United States District Court for the Northern District of California, Oakland Division, on November 20, 2026. The complaint says SōRSE brings the action under the Patent Act, 35 U.S.C. § 101 et seq. It alleges that Vertosa's methods for preparing cannabis emulsion products, which the complaint calls the Accused Methods, and Vertosa's services directing the manufacture of cannabis emulsion products by customers, which the complaint calls the Accused Services and Products, infringe U.S. Patent No. 12,551,416. SōRSE demands a trial by jury on all issues so triable, under Rule 38(b) of the Federal Rules of Civil Procedure.
The parties
The complaint says SōRSE Technology Corporation is a Delaware corporation with its principal place of business in Seattle, Washington. It says SōRSE entered the cannabis industry in 2016 and, in 2017, publicly commercialized a water-compatible emulsion method designed to provide uniform dosing, stability, improved sensory characteristics, and predictable consumer experiences. It says SōRSE has commercialized over 100 products with dozens of partners.
The complaint alleges, on information and belief, that Vertosa, Inc. is a corporation organized under the laws of Delaware, with its principal place of business in Walnut Creek, California. The complaint says Vertosa is a cannabis infusion company that advertises nanotechnology and microemulsion systems. It says Vertosa entered the market as Nanogen Labs in 2018, later rebranded to Vertosa in 2019, and began its commercial rollout in 2019.
The '416 patent
Count I is infringement of U.S. Patent No. 12,551,416 under 35 U.S.C. § 271. The complaint calls the patent the '416 patent and gives its title as "Method for Preparing Stable Liquid Emulsion Forms of Plant Extract." It says the patent was filed on November 20, 2023, issued on February 2, 2026, and is directed to methods for preparing stable liquid emulsion forms of plant extracts. The face of the patent uses that title and gives Application No. 18/514,659 and the same filing date. The face states that the patent has 20 claims and two drawing sheets.
The complaint says SōRSE owns all rights, title, and interest in the '416 patent, and holds all substantial rights pertinent to this suit, including the right to sue and recover for all past, current, and future infringement. It says the '416 patent is valid and enforceable and directed to patentable subject matter. It says that, as a matter of law, the notice provisions of 35 U.S.C. § 287 do not apply in this case and that SōRSE has satisfied its obligations under § 287.
The complaint alleges, on information and belief, that Vertosa was unable to successfully create an emulsion method until SōRSE published its first application, U.S. Patent Application No. 16/010,082, on December 20, 2018. The complaint says the '082 application is a parent to the '416 patent.
Claim 10
The complaint alleges that Vertosa has infringed and continues to infringe the '416 patent, directly and indirectly, literally or under the doctrine of equivalents, by using, or by making, importing, offering to sell, and/or selling products or processes that are used to practice one or more inventions claimed in the patent, including manufacturing cannabis emulsions in accordance with the claimed method. As an illustrative but nonexclusive example, the complaint alleges that Vertosa's manufacturing of cannabis emulsions infringes at least claim 10.
The complaint quotes claim 10: "A method for preparing stable liquid emulsion forms of plant extract, comprising: mixing a plant extract with diluent oil as an oil mixture; dispersing an emulsifying agent in water as an emulsifying solution; mixing the oil mixture and emulsifying solution; homogenizing the mixed oil mixture and emulsifying solution as a liquid form of the plant extract; mixing the liquid emulsion with an edible or drinkable item to be ingested by an individual and wherein upon ingestion, the liquid emulsion with the plant extract passes directly through the individual's stomach to enter the individual's digestive track where the plant extract is absorbed to reduce an amount of time in which effects of the plant extract commence, wherein droplets of the plant extract in the liquid emulsion each comprise a size less than 2 microns."
How the complaint maps claim 10
The complaint says the preamble of claim 10 is properly construed as non-limiting, and that if the preamble is limiting, the accused methods embody the claimed method for preparing stable liquid emulsion forms of plant extract. It alleges that Vertosa mixes a plant extract with diluent oil as an oil mixture, and it describes diluent oil as a carrier oil. It alleges, on information and belief, based on technical analysis of a sample of Vertosa emulsion obtained by SōRSE, that Vertosa mixes the plant extract with a diluent oil such as a medium chain triglyceride, MCT oil, or palm oil.
The complaint alleges that Vertosa disperses an emulsifying agent in water as an emulsifying solution. It alleges, on information and belief, based on technical analysis of a sample of Vertosa emulsion obtained by SōRSE, that Vertosa uses quillaja extract as an emulsifier. It alleges, on information and belief, that Vertosa mixes the emulsifying solution separately from the THC-oil mixture before mixing the two together. It alleges that if Vertosa instead mixes the THC-oil mixture, water, and emulsifier in a single step, that single step is equivalent because it performs substantially the same function, in substantially the same way, to achieve the same result.
The complaint alleges that Vertosa homogenizes the mixed oil mixture and emulsifying solution as a liquid form of the plant extract, and that Vertosa uses ultrasonication to do that homogenizing. It alleges that Vertosa's partners, either at the direction of Vertosa or in a joint enterprise with Vertosa, mix the liquid emulsion with an edible or drinkable item to be ingested by an individual and wherein upon ingestion, the liquid emulsion with the plant extract passes directly through the individual's stomach to enter the individual's digestive track where the plant extract is absorbed to reduce an amount of time in which effects of the plant extract commence, wherein droplets of the plant extract in the liquid emulsion each comprise a size less than 2 microns. The complaint points to Vertosa's Cannabis Beverage Manufacturing Handbook, and to a Vertosa webpage, for an emulsion with droplet sizes it says are smaller than 2 microns and for an onset time under 15 minutes.
Joint enterprise and direction
The complaint alleges, on information and belief, that the patented method of claim 10 is performed by a joint enterprise between Vertosa and its partners, such as cannabis product brands and edible cannabis product contract packagers, which the complaint calls co-packers. In the alternative, the complaint alleges, on information and belief, that Vertosa directs or controls the acts of its partners, including, on information and belief, by agreements that they follow steps in Vertosa's Cannabis Beverage Manufacturing Handbook, which Vertosa provides to potential customers on request.
The complaint alleges, on information and belief, that Vertosa uses substantially the same infringing process for all cannabis emulsion forms it provides to partners and customers. As an illustrative but nonexclusive example and on information and belief, the complaint alleges that Vertosa's manufacturing of cannabis emulsions, in a joint enterprise with its partners or through its direction of or conditions on its partners, practices each and every limitation of at least claim 10, and that Vertosa infringes the '416 patent each time it manufactures cannabis emulsions using the methods described above.
Sections 271(g) and 271(c)
The complaint alleges, on information and belief, that Vertosa manufactures cannabis emulsions using a method that practices each and every limitation of at least one claim of the '416 patent, in order to produce cannabis emulsions for sale by its customers. As an illustrative but nonexclusive example and on information and belief, the complaint alleges that each sale of cannabis emulsions, or of products containing cannabis emulsions, by Vertosa's customers, made according to the method of the '416 patent, is an act of infringement under 35 U.S.C. § 271(g).
As an illustrative but nonexclusive example and on information and belief, the complaint alleges that the cannabis emulsions manufactured by Vertosa, when sold to Vertosa's partners, have no substantial non-infringing uses and are especially made or especially adapted for infringement, and that each sale by Vertosa of its cannabis emulsions to its partners after Vertosa had actual notice of the '416 patent is an act of contributory infringement under 35 U.S.C. § 271(c).
Notice, willfulness, and damages
The complaint alleges, on information and belief, that Vertosa had actual notice of the '416 patent at least as early as the date on which Vertosa received a copy of the original complaint. It alleges that Vertosa's infringement of the '416 patent has been and remains willful and deliberate, starting from at least the date on which Vertosa received a copy of the original complaint. It says Vertosa's activities have been without SōRSE's authorization. It says that, as a result of Vertosa's infringement, SōRSE has been damaged and will be further damaged, and is entitled to compensation under 35 U.S.C. § 284 in an amount that presently cannot be ascertained, but that will be determined at trial.
The competition allegations
The complaint alleges, on information and belief, that Vertosa falsely represents to SōRSE's customers that its cannabis emulsions are of equivalent quality to SōRSE's emulsions and can be substituted one-for-one for SōRSE's emulsions in customers' formulations at a lower cost. It alleges, on information and belief, that Vertosa is undercutting SōRSE's sales with subpar emulsions using SōRSE's patented technology.
The complaint alleges, on information and belief, that Vertosa's infringing emulsions are the source of essentially all of Vertosa's revenue. It alleges, on information and belief, that Vertosa represents to SōRSE's customers that Vertosa's emulsions are technically indistinct from SōRSE's customized emulsions. It alleges, on information and belief, that Vertosa's products are of a lower quality than SōRSE's emulsions with respect to their stability, consistency, and flavor profiles. It alleges, on information and belief, that Vertosa's representations that its emulsions are technically indistinct from SōRSE's customized emulsions have caused and will continue to damage SōRSE by causing customers to choose to replace SōRSE emulsions with lower-quality Vertosa formulations.
The complaint alleges, on information and belief, that Vertosa is undercutting SōRSE's prices and selling its infringing emulsions at a loss to suppress prices and capture market share. It alleges, on information and belief, that Vertosa is operating at a loss on these sales.
Jurisdiction and venue
The complaint says this is an action arising under the patent laws of the United States, and that the court has subject matter jurisdiction under 28 U.S.C. §§ 1331 and 1338(a). It says the court has personal jurisdiction over Vertosa because Vertosa has its principal place of business in Walnut Creek, California, and because Vertosa made, used, and/or sold infringing products within the Northern District of California. It says venue is proper in this District under 28 U.S.C. §§ 1391(b)-(c) and 1400(b) because Vertosa's principal place of business is in this District, and Vertosa therefore resides in this District.
The prayer for relief
The prayer asks the court to enter judgment against Vertosa and against its subsidiaries, successors, parents, affiliates, officers, directors, agents, servants, employees, and all persons in active concert or participation with them. It asks for entry of judgment in favor of SōRSE and against Vertosa. It asks for damages adequate to make SōRSE whole for the patent infringement, including lost profits, but in no event less than a reasonable royalty as permitted by 35 U.S.C. § 284, together with prejudgment interest from the date the infringement began. It asks for enhanced damages for willful patent infringement of three times the amount of damages found or assessed, starting from the date on which Vertosa received a copy of the complaint, pursuant to 35 U.S.C. § 284. It asks for a finding that this case is exceptional and an award of reasonable attorneys' fees and costs as provided by 35 U.S.C. § 285. It asks for a permanent injunction prohibiting further infringement of the '416 patent. It asks for such other relief as the court deems just and proper.
What to watch next
Watch for an answer or a Rule 12 motion. The case can end at any time, including by settlement or voluntary dismissal.